|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.28 CNY | -4.15% |
|
-9.28% | -10.45% |
| Apr. 12 | Wantai Biological's Phase 3 Trials for Nine-Valent HPV Vaccine Yields Performed 'As Expected' | MT |
| Mar. 29 | Wantai BioPharm's 2023 Profit Drops 74% on Revenue Drop; Shares Slump 3% | MT |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 11,185.2 million compared to CNY 5,750.33 million a year ago. Net income was CNY 4,739.09 million compared to CNY 2,021.47 million a year ago.
Basic earnings per share from continuing operations was CNY 3.7929 compared to CNY 1.6429 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.45% | 12.3B | |
| -6.68% | 84.57B | |
| +3.95% | 39.93B | |
| -26.37% | 27.93B | |
| +52.09% | 24.21B | |
| -6.59% | 17.17B | |
| -32.37% | 13.93B | |
| -15.88% | 11.84B | |
| -2.85% | 7.91B | |
| +0.53% | 7.48B |
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. 
